Literature DB >> 21799155

Effects of extending the time window of thrombolysis to 4.5 hours: observations in the Swedish stroke register (riks-stroke).

Kjell Asplund1, Eva-Lotta Glader, Bo Norrving, Marie Eriksson.   

Abstract

BACKGROUND AND
PURPOSE: The European Cooperative Acute Stroke Study (ECASS) III trial and Safe Implementation of Thrombolysis in Stroke-International Stroke Thrombolysis Register (SITS-ISTR) data were published in 2008. Riks-Stroke, the Swedish Stroke Register, was used to explore how thrombolysis in the 3- to 4.5-hour window has been spread in different hospitals and patient groups and what effects this has had on treatment within 3 hours.
METHODS: All 76 hospitals in Sweden admitting patients with acute stroke participate in Riks-Stroke. During the study period, January 2003 to June 2010, 92 150 18- to 80-year-old patients were hospitalized for acute ischemic stroke.
RESULTS: After the publication of the ECASS III results in the third quarter of 2008, thrombolysis in the 3- to 4.5-hour window increased from 0.5% before publication to 2.1% in 2010. Thrombolysis in the 3- to 4.5-hour window spread somewhat faster in men than women (P=0.04) but at a similar rate in different age groups. The use of thrombolysis within 3 hours after onset of symptoms increased successively from 0.9% in 2003 to 6.6% in late 2008 and then it stabilized at 6%. The median time from arrival to the hospital to start of treatment remained unchanged at 66 to 69 minutes before and after 2008 (P=0.06).
CONCLUSIONS: Since the end of 2008, there has been a rapid nationwide dissemination of thrombolysis in the 3- to 4.5-hour window, whereas rates in the <3-hour window have leveled off. The extended time window has not affected door-to-needle time.

Entities:  

Mesh:

Year:  2011        PMID: 21799155     DOI: 10.1161/STROKEAHA.111.618587

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  11 in total

1.  Acute stroke reperfusion therapy trends in the expanded treatment window era.

Authors:  Ganesh Asaithambi; Xin Tong; Mary G George; Albert W Tsai; James M Peacock; Russell V Luepker; Kamakshi Lakshminarayan
Journal:  J Stroke Cerebrovasc Dis       Date:  2014-08-23       Impact factor: 2.136

2.  In-room assessment of cerebral blood volume for guidance during intra-arterial thrombolytic therapy.

Authors:  C-J Lin; M Yu; S-C Hung; M M H Teng; W-Y Guo; F-C Chang; C-B Luo; W-F Chu; C-Y Chang
Journal:  Interv Neuroradiol       Date:  2012-12-03       Impact factor: 1.610

3.  The quality of treatment of hyperacute ischemic stroke in Canada: a retrospective chart audit.

Authors:  Aravind Ganesh; Marie Camden; Patrice Lindsay; Moira K Kapral; Robert Coté; Jiming Fang; Brandon Zagorski; Michael Douglas Hill
Journal:  CMAJ Open       Date:  2014-10-01

Review 4.  Extending the Time Window for Endovascular and Pharmacological Reperfusion.

Authors:  Nils Henninger; Marc Fisher
Journal:  Transl Stroke Res       Date:  2016-01-07       Impact factor: 6.829

5.  Improving thrombolysis for acute ischemic stroke in Lombardia stroke centers.

Authors:  A Cavallini; E Tartara; S Marcheselli; E Agostoni; S Quaglini; G Micieli
Journal:  Neurol Sci       Date:  2013-02-08       Impact factor: 3.307

6.  Who does it first? The uptake of medical innovations in the performance of thrombolysis on ischemic stroke patients in Germany: a study based on hospital quality data.

Authors:  Nadine Scholten; Holger Pfaff; Helmar C Lehmann; Gereon R Fink; Ute Karbach
Journal:  Implement Sci       Date:  2015-01-13       Impact factor: 7.327

7.  Outcome of stroke patients receiving different doses of recombinant tissue plasminogen activator.

Authors:  Cheung-Ter Ong; Yi-Sin Wong; Chi-Shun Wu; Yu-Hsiang Su
Journal:  Drug Des Devel Ther       Date:  2017-05-18       Impact factor: 4.162

8.  Nationwide temporal trend analysis of reperfusion therapy utilization and mortality in acute ischemic stroke patients in Japan.

Authors:  Megumi Maeda; Haruhisa Fukuda; Ryu Matsuo; Fumi Kiyuna; Tetsuro Ago; Takanari Kitazono; Masahiro Kamouchi
Journal:  Medicine (Baltimore)       Date:  2021-01-08       Impact factor: 1.817

9.  Comparative evaluation of treatment with low-dose aspirin plus dipyridamole versus aspirin only in patients with acute ischaemic stroke.

Authors:  Lola Arnarsdottir; Clara Hjalmarsson; Lena Bokemark; Björn Andersson
Journal:  BMC Neurol       Date:  2012-08-06       Impact factor: 2.474

10.  Using aggregated data from Swedish national quality registries as tools to describe health conditions of older adults with complex needs.

Authors:  Linda Johansson; Deborah Finkel; Christina Lannering; Anna K Dahl Aslan; Boel Andersson-Gäre; Jenny Hallgren; Ulrika Lindmark; Marie Ernsth Bravell
Journal:  Aging Clin Exp Res       Date:  2020-06-13       Impact factor: 4.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.